Genetic analysis of factors affecting susceptibility of bacillus subtilis to daptomycinvt

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1598-1609

  Hachmann, Anna Barbara ^a   Angert, Esther R ^a   Helmann, John D ^a  

^a Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; LIPID DESATURASE; LYSINE; MEMBRANE PROTEIN; PHAGE SHOCK PROTEIN A; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; AUTOREGULATION; BACILLUS SUBTILIS; BACTERIAL STRAIN; CELL DIVISION; CELL MEMBRANE; CELLULAR DISTRIBUTION; DNA SEQUENCE; DRUG SENSITIVITY; ENVELOPE GENE; FLUORESCENCE MICROSCOPY; GENE DELETION; GENETIC ANALYSIS; GENETIC CODE; LIPID COMPOSITION; MUTANT; OPERON; PRIORITY JOURNAL; PROTEIN DEPLETION; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION INITIATION;

ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; BACTERIAL PROTEINS; CELL WALL; CLUSTER ANALYSIS; DAPTOMYCIN; HEAT-SHOCK PROTEINS; MEMBRANE LIPIDS; MICROBIAL SENSITIVITY TESTS; OPERON; REGULON; SIGMA FACTOR;

EID: 65649154706     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01329-08     Document Type: Article

References (62)

1. Antelmann, H., S. Towe, D. Albrecht, and M. Hecker. 2007. The phosphorus source phytate changes the composition of the cell wall proteome in Bacillus subtilis. J. Proteome Res. 6:897-903.
2. Barák, L, K. Muchova, A. J. Wilkinson, P. J. O'Toole, and N. Pavlendova. 2008. Lipid spirals in Bacillus subtilis and their role in cell division. MoI. Microbiol. 68:1315-1327.
3. Bisicchia, P., D. Noone, E. Lioliou, A. Howell, S. Quigley, T. Jensen, H. Jarmer, and K. M. Devine. 2007. The essential YycFG two-component system controls cell wall metabolism in Bacillus subtilis. MoI. Microbiol. 65:180-200. (Pubitemid 46938543)
4. Butcher, B. G., and J. D. Helmann. 2006. Identification of Bacillus subtilis sigma-dependent genes that provide intrinsic resistance to antimicrobial compounds produced by bacilli. MoI. Microbiol. 60:765-782.
5. Campo, N., H. Tjalsma, G. Buist, D. Stepniak, M. Meyer, M. Veenhuis, M. Westermann, J. P. Muller, S. Bron, J. Kok, O. P. Kuipers, and J. D. Jong-bloed. 2004. 53:1583-1599. (Pubitemid 39265308)
6. Canepari, P., and M. Boaretti. 1996. Lipoteichoic acid as a target for anti-microbial action. Microb. Drug Resist. 2:85-89. (Pubitemid 26259105)
7. Cao, M., B. A. Bernât, Z. Wang, R. N. Armstrong, and J. D. Helmann. 2001. FosB, a cysteine-dependent fosfomycin resistance protein under the control of o-w, an extracytoplasmic-function o-factor in Bacillus subtilis. J. Bacteriol. 183:2380-2383. (Pubitemid 32240412)
8. Cao, M., and J. D. Helmann. 2004. The Bacillus subtilis extracytoplasmic-function crx factor regulates modification of the cell envelope and resistance to cationic antimicrobial peptides. J. Bacteriol. 186:1136-1146. (Pubitemid 38209474)
9. Cao, M., and J. D. Helmann. 2002. Regulation of the Bacillus subtilis bcrC bacitracin resistance gene by two extracytoplasmic function o-factors. J. Bacteriol. 184:6123-6129. (Pubitemid 35265892)
10. Cao, M., P. A. Kobel, M. M. Morshedi, M. F. Wu, C. Paddon, and J. D. Helmann. 2002. Defining the Bacillus subtilis o-w regulon: a comparative analysis of promoter consensus search, run-off transcription/macroarray analysis (ROMA), and transcriptional profiling approaches. J. MoI. Biol. 316:443-457. (Pubitemid 34729233)
11. Cao, M., C. M. Moore, and J. D. Helmann. 2005. Bacillus subtilis paraquat resistance is directed by o-M, an extracytoplasmic function o-factor, and is conferred by YqjL and BcrC. J. Bacteriol. 187:2948-2956. (Pubitemid 40571586)
12. Cao, M., T. Wang, R. Ye, and J. D. Helmann. 2002. Antibiotics that inhibit cell wall biosynthesis induce expression of the Bacillus subtilis o-w and o-M régulons. Mol. Microbiol. 45:1267-1276.
13. Cotroneo, N., R. Harris, N. Perlmutter, T. Beveridge, and J. A. Silverman. 2008. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus. Antimicrob. Agents Chemother. 52:2223-2225.
14. Daniel, R. A., and J. Errington. 2003. Control of cell morphogenesis in bacteria: two distinct ways to make a rod-shaped cell. Cell 113:767-776. (Pubitemid 36724940)
15. Darwin, A. J. 2005. The phage-shock-protein response. MoI. Microbiol. 57:621-628. (Pubitemid 41025946)
16. D'Costa, V. M., K. M. McGrann, D. W. Hughes, and G. D. Wright. 2006. Sampling the antibiotic resistome. Science 311:374-377. (Pubitemid 43132661)
17. Eiamphungporn, W., and J. D. Helmann. 2008. The Bacillus subtilis o-M regulon and its contribution to cell envelope stress responses. MbI. Micro-biol. 67:830-848.
18. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sei. USA 95:14863-14868. (Pubitemid 29003722)
19. Ellermeier, C. D., E. C. Hobbs, J. E. Gonzalez-Pastor, and R. Losick. 2006. A three-protein signaling pathway governing immunity to a bacterial canni-balism toxin. Cell 124:549-559. (Pubitemid 43199440)
20. Falagas, M. E., K. P. Giannopoulou, F. Ntziora, and K. Z. Vardakas. 2007. Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence. J. Antimicrob. Chemother. 60:7-19. (Pubitemid 47073272)
21. Friedman, L., J. D. Alder, and J. A. Silverman. 2006. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:2137-2145. (Pubitemid 43807536)
22. Gardete, S., S. W. Wu, S. Gill, and A. Tomasz. 2006. Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:3424-3434. (Pubitemid 44527519)
23. Hair, P. I., and S. J. Keam. 2007. Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococ-cus aureus bacteraemia. Drugs 67:1483-1512. (Pubitemid 47028521)
24. Ho, S. W., D. Jung, J. R. Calhoun, J. D. Lear, M. Okon, W. R. Scott, R. E. Hancock, and S. K. Straus. 2008. Effect of divalent cations on the structure of the antibiotic daptomycin. Eur. Biophys. J. 37:421-433.
25. Holmes, R. L., and J. H. Jorgensen. 2008. Inhibitory activities of 11 antimi-crobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006. Antimicrob. Agents Chemother. 52:757-760.
26. Horsburgh, M. J., and A. Moir. 1999. o-M, an ECF RNA polymerase sigma factor of Bacillus subtilis 168, is essential for growth and survival in high concentrations of salt. MoI. Microbiol. 32:41-50.
27. Huang, X., A. Decatur, A. Sorokin, and J. D. Helmann. 1997. The Bacillus subtilis crx protein is an extracytoplasmic function o-factor contributing to survival at high temperature. J. Bacteriol. 179:2915-2921. (Pubitemid 27194439)
28. Huang, X., K. L. Fredrick, and J. D. Helmann. 1998. Promoter recognition by Bacillus subtilis o-w: autoregulation and partial overlap with the o* regu-lon. J. Bacteriol. 180:3765-3770. (Pubitemid 28361568)
29. Huang, X., A. Gaballa, M. Cao, and J. D. Helmann. 1999. Identification of target promoters for the Bacillus subtilis extracytoplasmic function sigma factor,
30. Hutter, B., C. Schaab, S. Albrecht, M. Borgmann, N. A. Brunner, C. Freiberg, K. Ziegelbauer, C. O. Rock, I. Ivanov, and H. Loferer. 2004. Prediction of mechanisms of action of antibacterial compounds by gene expression profiling. Antimicrob. Agents Chemother. 48:2838-2844. (Pubitemid 38989144)
31. Iwamoto, K., T. Hayakawa, M. Múrate, A. Makino, K. Ito, T. Fujisawa, and T. Kobayashi. 2007. Curvature-dependent recognition of ethanolamine phospholipids by duramycin and cinnamycin. Biophys. J. 93:1608-1619. (Pubitemid 47403302)
32. Jervis, A. J., P. D. Thackray, C. W. Houston, M. J. Horsburgh, and A. Moir. 2007. o-M-responsive genes oí Bacillus subtilis and their promoters. J. Bacte-riol. 189:4534-4538. (Pubitemid 46919642)
33. Jones, T., M. R. Yeaman, G. Sakoulas, S.-J. Yang, R. A. Proctor, H.-G. Sahl, J. Schrenzel, Y. Q. Xiong, and A. S. Bayer. 2008. Staphylococcus aureus clinical treatment failures with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. An-timicrob. Agents Chemother. 52:269-278.
34. Jordan, S., M. I. Hutchings, and T. Mascher. 2008. Cell envelope stress response in gram-positive bacteria. FEMS Microbiol. Rev. 32:107-146. (Pubitemid 350293914)
35. Jordan, S., A. Junker, J. D. Helmann, and T. Mascher. 2006. Regulation of LiaRS-dependent gene expression in Bacillus subtilis: identification of inhib-itor proteins, regulator binding sites, and target genes of a conserved cell envelope stress-sensing two-component system. J. Bacteriol. 188:5153-5166. (Pubitemid 44051481)
36. Jovanovic, G., L. J. Lloyd, M. P. Stumpf, A. J. Mayhew, and M. Buck. 2006. Induction and function of the phage shock protein extracytoplasmic stress response in Escherichia coli. J. Biol. Chem. 281:21147-21161. (Pubitemid 44115455)
37. Jung, D., J. P. Powers, S. K. Straus, and R. E. Hancock. 2008. Lipid-specific binding of the calcium-dependent antibiotic daptomycin leads to changes in lipid polymorphism of model membranes. Chem. Fhys. Lipids 154:120-128.
38. Kato, Y., T. Suzuki, T. Ida, K. Maebashi, M. Sakurai, J. Shiotani, and I. Hayashi. 2008. Microbiological and clinical study of methicillin-resistant Staphylococcus aureus (MRSA) carrying VraS mutation: changes in suscep-tibility to glycopeptides and clinical significance. Int. J. Antimicrob. Agents 31:64-70. (Pubitemid 350236725)
39. Kobayashi, R., T. Suzuki, and M. Yoshida. 2007. Escherichia coli phage-shock protein A (PspA) binds to membrane phospholipids and repairs pro-ton leakage of the damaged membranes. MbI. Microbiol. 66:100-109. (Pubitemid 47414790)
40. Laganas, V., J. Alder, and J. A. Silverman. 2003. In vitro bactericidal activ-ities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis. Antimicrob. Agents Chemother. 47:2682-2684. (Pubitemid 36919481)
41. MacLellan, S., T. Wecke, and J. Helmann. 2008. A previously unidentified cr factor and two accessory proteins regulate oxalate decarboxylase expression in Bacillus subtilis. MoI. Microbiol. 69:954-967.
42. 41a.Mansilla, M. C, and D. de Mendoza. 2005. The Bacillus subtilis desaturase: a model to understand phospholipid modification and temperature sensing. Arch. Microbiol. 183:229-235. (Pubitemid 40768012)
43. Mascher, T., A. B. Hachmann, and J. D. Helmann. 2007. Regulatory overlap and functional redundancy among Bacillus subtilis extracytoplasmic function o-factors. J. Bacteriol. 189:6919-6927. (Pubitemid 47525436)
44. Mascher, T., N. G. Margulis, T. Wang, R. W. Ye, and J. D. Helmann. 2003. Cell wall stress responses in Bacillus subtilis: the regulatory network of the bacitracin stimulon. MoI. Microbiol. 50:1591-1604. (Pubitemid 38010455)
45. Mascher, T., S. L. Zimmer, T. A. Smith, and J. D. Helmann. 2004. Antibi-otic-inducible promoter regulated by the cell envelope stress-sensing two-component system LiaRS of Bacillus subtilis. Antimicrob. Agents Che-mother. 48:2888-2896. (Pubitemid 38989152)
46. Mascio, C. T., J. D. Alder, and J. A. Silverman. 2007. Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob. Agents Chemother. 51:4255-4260. (Pubitemid 350209874)
47. Miao, V., M. F. Coeffet-Legal, P. Brian, R. Brost, J. Penn, A. Whiting, S. Martin, R. Ford, I. Parr, M. Bouchard, C. J. Silva, S. K. Wrigley, and R. H. Baltz. 2005. Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology 151:1507-1523. (Pubitemid 40711798)
48. Muthaiyan, A., J. A. Silverman, R. K. Jayaswal, and B. J. Wilkinson. 2008. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolar-ization. Antimicrob. Agents Chemother. 52:980-990.
49. Nanamiya, H., K. Kasai, A. Nozawa, C. S. Yun, T. Narisawa, K. Murakami, Y. Natori, F. Kawamura, and Y. Tozawa. 2008. Identification and functional analysis of novel (p)ppGpp synthetase genes in Bacillus subtilis. MbI. Micro-biol. 67:291-304. (Pubitemid 350295828)
50. Nishi, H., H. Komatsuzawa, T. Fujiwara, N. McCallum, and M. Sugai. 2004. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob. Agents Che-mother. 48:4800-4807. (Pubitemid 39577687)
51. Reynolds, P. E., and E. A. Somner. 1990. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics. Drugs Exp. Clin. Res. 16:385-389.
52. Salzberg, L. L, and J. D. Helmann. 2007. An antibiotic-inducible cell wall-associated protein that protects Bacillus subtilis from autolysis. J. Bacteriol. 189:4671-4680. (Pubitemid 47025578)
53. Salzberg, L. L, and J. D. Helmann. 2008. Phenotypic and transcriptomic characterization of Bacillus subtilis mutants with grossly altered membrane composition. J. Bacteriol. 190:7797-7807.
54. Scheffers, D. J., L. J. Jones, and J. Errington. 2004. Several distinct local-ization patterns for penicillin-binding proteins in Bacillus subtilis. MoI. Mi-crobiol. 51:749-764. (Pubitemid 38233941)
55. Scott, W. R., S. B. Baek, D. Jung, R. E. Hancock, and S. K. Straus. 2007. NMR structural studies of the antibiotic lipopeptide daptomycin in DHFC micelles. Biochim. Biophys. Acta 1768:3116-3126. (Pubitemid 350236091)
56. Silverman, J. A., N. Oliver, T. Andrew, and T. Li. 2001. Resistance studies with daptomycin. Antimicrob. Agents Chemother. 45:1799-1802. (Pubitemid 32466351)
57. Silverman, J. A., N. G. Perlmutter, and H. M. Shapiro. 2003. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylo-coccus aureus. Antimicrob. Agents Chemother. 47:2538-2544. (Pubitemid 36919456)
58. Staubitz, P., H. Neumann, T. Schneider, I. Wiedemann, and A. Peschel. 2004. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an impor-tant determinant in staphylococcal defensin resistance. FEMS Microbiol. Lett. 231:67-71. (Pubitemid 38180561)
59. Tiyanont, K., T. Doan, M. B. Lazarus, X. Fang, D. Z. Rudner, and S. Walker. 2006. Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics. Froc. NaU. Acad. Sei. USA 103:11033-11038. (Pubitemid 44148413)
60. Vander Horn, P. B., and S. A. Zahler. 1992. Cloning and nucleotide sequence of the leucyl-tRNA synthetase gene of Bacillus subtilis. J. Bacteriol. 174: 3928-3935.
61. Wach, A. 1996. PCR-synthesis of marker cassettes with long flanking homol-ogy regions for gene disruptions in S. cerevisiae. Yeast 12:259-265. (Pubitemid 26077146)
62. Wecke, T., D. Zühlke, U. Mäder, S. Jordan, B. Voigt, S. Pelzer, H. Labischinski, G. Homuth, M. Hecker, and T. Mascher. 2009. Daptomycin versus friulimicin B: in-depth profiling oiBacillus subtilis cell envelope stress responses. Antimicrob. Agents Chemother. 53:1619-1623.